Mechanisms of gemcitabine oral absorption as determined by in situ intestinal perfusions in mice
Author:
Funder
National Institutes of Health
National Institute of General Medical Sciences
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference42 articles.
1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J. Clin. Oncol.,1997
2. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG;Pfisterer;J. Clin. Oncol.,2006
3. Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment;Albain;J. Clin. Oncol.,2008
4. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non–small-cell lung cancer;Sandler;J. Clin. Oncol.,2000
5. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29;Young;Mol. Aspects Med.,2013
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy;Journal of Colloid and Interface Science;2025-01
2. Oleandrin: A Systematic Review of its Natural Sources, Structural Properties, Detection Methods, Pharmacokinetics and Toxicology;Frontiers in Pharmacology;2022-02-21
3. Tri-2-Hydroxyarachidonein Induces Cytocidal Autophagy in Pancreatic Ductal Adenocarcinoma Cancer Cell Models;Frontiers in Physiology;2022-01-20
4. Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration;Current Issues in Molecular Biology;2021-12-07
5. In Silico Docking of Anti Cancerous Drugs with β-Cyclodextrin polymer as a Prominent Approach to Improve the Bioavailability;Anti-Cancer Agents in Medicinal Chemistry;2021-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3